Silver Nanoparticles Interactions with the Immune System: Implications for Health and Disease
暂无分享,去创建一个
David Pozo | Ana Paula Zaderenko | Paula M. Castillo | Rebecca Klippstein | D. Pozo | A. P. Zaderenko | R. Klippstein | Rafael Fernandez-Montesinos | P. M. Castillo | R. Fernández‐Montesinos
[1] Priyabrata Mukherjee,et al. Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.
[2] J. Maessen,et al. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. , 2009, Biomaterials.
[3] S. Paludan,et al. Innate recognition of intracellular pathogens: detection and activation of the first line of defense , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[4] S. Silver,et al. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds , 2006, Journal of Industrial Microbiology and Biotechnology.
[5] Seung-Heon Shin,et al. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. , 2007, International immunopharmacology.
[6] R. Albrecht,et al. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. , 2009, Small.
[7] M. Harboe,et al. Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis , 2009, Scandinavian journal of immunology.
[8] Nakissa Sadrieh,et al. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. , 2009, Advanced drug delivery reviews.
[9] P. Tam,et al. Further Evidence of the Anti‐inflammatory Effects of Silver Nanoparticles , 2009, ChemMedChem.
[10] S. Akira,et al. The role of Toll-like receptors in immune disorders , 2006, Expert opinion on biological therapy.
[11] X. Chen,et al. Nanosilver: a nanoproduct in medical application. , 2008, Toxicology letters.
[12] Ruchi Yadav,et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[13] C. Walker,et al. Toll-like receptors as potential therapeutic targets for multiple diseases , 2002, Nature Reviews Drug Discovery.
[14] F. Lowy,et al. Antimicrobial-resistant bacteria in the community setting , 2006, Nature Reviews Microbiology.
[15] H. Klasen,et al. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. , 2000, Burns : journal of the International Society for Burn Injuries.
[16] Andreas Zimmer,et al. A practical note on the use of cytotoxicity assays. , 2005, International journal of pharmaceutics.
[17] J. Luk,et al. Silver Nanoparticles Inhibit Hepatitis B virus Replication , 2008, Antiviral therapy.
[18] T. Krieg,et al. Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.
[19] M. Yacamán,et al. Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.
[20] A. Thomsen,et al. Co‐ordinating innate and adaptive immunity to viral infection: mobility is the key , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[21] A. Singh,et al. Synthesis of Ag-Pt alloy nanoparticles in aqueous bovine serum albumin foam and their cytocompatibility against human gingival fibroblasts. , 2009, Colloids and surfaces. B, Biointerfaces.
[22] Dae Hong Jeong,et al. Antimicrobial effects of silver nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[23] M. Rai,et al. Silver nanoparticles as a new generation of antimicrobials. , 2009, Biotechnology advances.
[24] J. Gearhart,et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[25] S. Hsu,et al. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. , 2009, Small.
[26] J. Yi,et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[27] K. Paknikar,et al. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. , 2009, Molecular pharmaceutics.
[28] P. Schechter,et al. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis , 2005, The British journal of dermatology.
[29] H. Moutsopoulos,et al. Wound healing: immunological aspects. , 2006, Injury.
[30] L. E. Fernández,et al. Innate‐immunity cytokines induced by very small size proteoliposomes, a Neisseria‐derived immunological adjuvant , 2007, Clinical and experimental immunology.
[31] B. Gibbins,et al. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.
[32] J. Guggenbichler,et al. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. , 2004, International journal of antimicrobial agents.
[33] M. Razzaque,et al. Immunoinflammatory responses and fibrogenesis , 2004, Medical Electron Microscopy.
[34] J. Alexander,et al. History of the medical use of silver. , 2009, Surgical infections.
[35] K. Wong,et al. Topical Delivery of Silver Nanoparticles Promotes Wound Healing , 2007, ChemMedChem.
[36] J. Schlager,et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[37] Diana Boraschi,et al. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. , 2004, European cytokine network.
[38] A. Makkouk,et al. The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents , 2009, Immunopharmacology and immunotoxicology.
[39] D. Pozo,et al. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. , 2008, Nanomedicine.
[40] M. Epple,et al. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs) , 2009, Langenbeck's Archives of Surgery.
[41] M. Hande,et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.
[42] Cato T. Laurencin,et al. Nanofibers and nanoparticles for orthopaedic surgery applications. , 2008, The Journal of bone and joint surgery. American volume.
[43] Da-Guang Yu. Formation of colloidal silver nanoparticles stabilized by Na+-poly(gamma-glutamic acid)-silver nitrate complex via chemical reduction process. , 2007, Colloids and surfaces. B, Biointerfaces.
[44] I. Sondi,et al. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.
[45] P. Schechter,et al. Effects of Nanocrystalline Silver (NPI 32101) in a Rat Model of Ulcerative Colitis , 2007, Digestive Diseases and Sciences.
[46] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.